Effect of fractional exhaled nitric oxide (FENO)-based asthma management during pregnancy versus usual care on infant development, temperament, sensory function and autism signs

- Whalen, Olivia M., Campbell, Linda E., Murphy, Vanessa E., Lane, Alison E., Karayanidis, Frini, Mallise, Carly A., Woolard, Alix J., Holliday, Elizabeth G., Mattes, Joerg, Collison, Adam, Gibson, Peter G.

Characterization of severe asthma worldwide: data from the International Severe Asthma Registry

- Wang, Eeileen, Wechsler, Michael E., Tran, Trung N., Heaney, Liam G., Jones, Rupert C., Menzies-Gow, Andrew N, Busby, John, Jackson, David J., Pfeffer, Paul E., Rhee, Chin Kook, Cho, You Sook, Canonica, G. Walter, Heffler, Enrico, Gibson, Peter G., Hew, Mark, Peters, Matthew, Harvey, Erin S., Alacqua, Marianna, Zangrilli, James, Bulathsinhala, Lakmini

How maternal BMI modifies the impact of personalized asthma management in pregnancy

- Murphy, Vanessa E., Jensen, Megan E., Robijn, Annelies L., Wright, Thomas K., Mattes, Joerg, Collison, Adam, Gibson, Peter G.

The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health

- Murphy, Vanessa E., Jensen, Megan E., Colditz, Paul B., Seeho, Sean K., Attia, John, Searles, Andrew, Doran, Christopher, Powell, Heather, Gibson, Peter G., Mattes, Joerg, Hensley, Michael J., Giles, Warwick B., Peek, Michael J., Bisits, Andrew, Callaway, Leonie K., McCaffery, Kirsten, Barrett, Helen L.